Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Lin Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8419-3350; OpenAlex author ID A5077600873. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Preoperative assessment in lymph node metastasis of pancreatic ductal adenocarcinoma: a transformer model based on dual-energy CT. Co-author DOI 10.1186/s12957-025-03774-6↗
  2. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer. Last author DOI 10.1097/md.0000000000023863↗
  3. Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer. Last author DOI 10.3389/fonc.2020.520330↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lei Li · 1 shared paper, 2025 · strength 0.28
  2. Xia Ding · 1 shared paper, 2025 · strength 0.28
  3. Ailing Zhong · 2 shared papers, 2020 · strength 0.28
  4. Chien‐shan Cheng · 1 shared paper, 2020 · strength 0.15
  5. Yiwen Yu · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.